Seattle-based Fred Hutchinson Cancer Center reported an operating income of $33.9 million (2.5% operating margin) in the first half of fiscal 2026, down from an operating income of $84.3 million (6.8% margin) during the same period last year.
Fred Hutch reported total operating revenue of $1.3 billion for the six months ended Dec. 31, up from $1.2 billion during the same period last year. Patient service revenue was $909.3 million, up from $762.5 million. Research grants and contracts totaled $247.1 million, up from $241.2 million. Investment income and realized gains totaled $36.6 million, down from $116 million.
Total operating expenses were $1.3 billion in the first half of 2026, up from $1.2 billion during the same period last year. Salaries, wages and benefits totaled $439.8 million, up from $415.7 million. Supply expenses totaled $425.3 million, up from $342.9 million. Other operating expenses totaled $101.5 million, up from $80.8 million.
Fred Hutch reported a net income of $83 million in the first half of 2026, up from $19.6 million during the same period last year.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.